Your migraine research study application has been received.
In this study we want to evaluate an investigational medication for the treatment of migraine headaches. Study participants will receive study medication or placebo to treat one migraine attack during a 4-week treatment period. Study participants may then have the option to enroll in a second 8-week open-label treatment period during which they will be provided only active study medication (no placebo).
If you qualify, you will receive study-related exams and study medication at no cost. In addition, you may be compensated for your time and travel expenses.
One of our Research Nurses will reach out to you within 24 to 48 hours. Alternatively, you may contact us during business hours, Monday through Friday between 8:00 a.m. and 5:00 p.m. by calling (734) 677-6000 and selecting option 4.
